Nanoscale devices have the potential to radically change cancer therapy for the better and to dramatically increase the number of highly effective therapeutic agents.

 nanoparticles are targeted to cancer cells for utilization in the molecular imaging of a malignant lesion. Large numbers of nanoparticles are safely injected into the physical body and preferentially attach to the cancer cells, defining the contour shape of the lesion and making it visible.

These nanoparticles provide us the capability to view cells and molecules that we otherwise cannot detect through conventional imaging. The capability to observe what happens in the cell and to monitor therapeutic intervention, along with viewing when a cancer cell is mortally damaged or is actually activated, is critical to the successful medical diagnosis and medical care of the illness.

Nanoparticulate technology can prove to be very useful in cancer medical care allowing for effective and targeted drug delivery by overcoming the many biological, biophysical and biomedical impediments that the physical body mounts against a standard intervention such as the administration of medicinal drugs or contrast agents.”